The European Physical Journal Special Topics.
2025.
Radiopharmaceuticals Based on Somatostatin Analogs and Technetium-99m Radionuclide for Diagnosis of Neuroendocrine Tumors: a Literature Review
Introduction Somatostatin receptor imaging capabilities Radiopharmaceuticals based on somatostatin receptors agonists and technetium-99m Radiopharmaceuticals based on somatostatin receptors antagonists and technetium-99m Conclusion. © 2025, A.I. Burnazyan Federal Medical Biophysical Center. All rights reserved.
Authors
Tishchenko V.K. ,
Vlasova O.P. ,
Ivanov S.A. ,
Kaprin A.D.
Number of issue
1
Language
Russian
Pages
93-101
Status
Published
Link
Volume
70
Year
2025
Organizations
- 1 A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Centre, Obninsk, Russian Federation
- 2 National Medical Research Radiological Center, Moscow, Russian Federation
- 3 Рeoples Friendship University of Russia, Moscow, Russian Federation
- 4 P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Moscow, Russian Federation
Keywords
neuroendocrine tumors; radionuclide diagnosis; radiopharmaceuticals; somatostatin analogs; technetium-99m
Share
Other records
Frontiers in Clinical Diabetes and Healthcare.
Frontiers Media SA.
Vol. 6.
2025.